| 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure P Ponikowski, AA Voors, SD Anker, H Bueno, JGF Cleland, AJS Coats, ... Kardiologia Polska (Polish Heart Journal) 74 (10), 1037-1147, 2016 | 24288* | 2016 |
| 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS P Kirchhof, S Benussi, D Kotecha, A Ahlsson, D Atar, B Casadei, ... Polish Heart Journal (Kardiologia Polska) 74 (12), 1359-1469, 2016 | 12254 | 2016 |
| ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 … Authors/Task Force Members, JJV McMurray, S Adamopoulos, SD Anker, ... European heart journal 33 (14), 1787-1847, 2012 | 11284 | 2012 |
| How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the … B Pieske, C Tschöpe, RA De Boer, AG Fraser, SD Anker, E Donal, ... European heart journal 40 (40), 3297-3317, 2019 | 1440 | 2019 |
| Effect of nesiritide in patients with acute decompensated heart failure CM O'Connor, RC Starling, AF Hernandez, PW Armstrong, K Dickstein, ... New England Journal of Medicine 365 (1), 32-43, 2011 | 1438 | 2011 |
| Sotagliflozin in patients with diabetes and recent worsening heart failure DL Bhatt, M Szarek, PG Steg, CP Cannon, LA Leiter, DK McGuire, ... New England journal of medicine 384 (2), 117-128, 2021 | 1415 | 2021 |
| The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial SD Solomon, M Zile, B Pieske, A Voors, A Shah, E Kraigher-Krainer, V Shi, ... The Lancet 380 (9851), 1387-1395, 2012 | 1392 | 2012 |
| Angiotensin‐converting enzyme 2 (ACE2), SARS‐CoV‐2 and the pathophysiology of coronavirus disease 2019 (COVID‐19) AR Bourgonje, AE Abdulle, W Timens, JL Hillebrands, GJ Navis, ... The Journal of pathology 251 (3), 228-248, 2020 | 1256 | 2020 |
| EURObservational Research Programme: regional differences and 1‐year follow‐up results of the Heart Failure Pilot Survey (ESC‐HF Pilot) AP Maggioni, U Dahlström, G Filippatos, O Chioncel, MC Leiro, J Drozdz, ... European journal of heart failure 15 (7), 808-817, 2013 | 1143 | 2013 |
| Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis K Damman, MAE Valente, AA Voors, CM O'Connor, DJ van Veldhuisen, ... European heart journal 35 (7), 455-469, 2014 | 1069 | 2014 |
| Vericiguat in patients with heart failure and reduced ejection fraction PW Armstrong, B Pieske, KJ Anstrom, J Ezekowitz, AF Hernandez, ... New England Journal of Medicine 382 (20), 1883-1893, 2020 | 1037 | 2020 |
| Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial JR Teerlink, G Cotter, BA Davison, GM Felker, G Filippatos, ... The Lancet 381 (9860), 29-39, 2013 | 1036 | 2013 |
| Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease K Damman, VM van Deursen, G Navis, AA Voors, DJ van Veldhuisen, ... Journal of the American College of Cardiology 53 (7), 582-588, 2009 | 1035 | 2009 |
| Iron deficiency in chronic heart failure: an international pooled analysis IJT Klip, J Comin-Colet, AA Voors, P Ponikowski, C Enjuanes, ... American heart journal 165 (4), 575-582. e3, 2013 | 865 | 2013 |
| Impaired systolic function by strain imaging in heart failure with preserved ejection fraction E Kraigher-Krainer, AM Shah, DK Gupta, A Santos, B Claggett, B Pieske, ... Journal of the American College of Cardiology 63 (5), 447-456, 2014 | 837 | 2014 |
| Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction RA de Boer, DJA Lok, T Jaarsma, P van der Meer, AA Voors, HL Hillege, ... Annals of medicine 43 (1), 60-68, 2011 | 796 | 2011 |
| Galectin‐3: a novel mediator of heart failure development and progression RA de Boer, AA Voors, P Muntendam, WH van Gilst, DJ van Veldhuisen European journal of heart failure 11 (9), 811-817, 2009 | 792 | 2009 |
| Outcome of pregnancy in women with congenital heart disease: a literature review W Drenthen, PG Pieper, JW Roos-Hesselink, WA van Lottum, AA Voors, ... Journal of the American College of Cardiology 49 (24), 2303-2311, 2007 | 784 | 2007 |
| Predictors of pregnancy complications in women with congenital heart disease W Drenthen, E Boersma, A Balci, P Moons, JW Roos-Hesselink, ... European heart journal 31 (17), 2124-2132, 2010 | 760 | 2010 |
| Worsening renal function and prognosis in heart failure: systematic review and meta-analysis K Damman, G Navis, AA Voors, FW Asselbergs, TDJ Smilde, JGF Cleland, ... Journal of cardiac failure 13 (8), 599-608, 2007 | 740 | 2007 |
